A landmark Rutgers Health study published in JAMA Network Opendemonstrates that over-the-counter pain medications provide equal or superior pain relief compared to opioid combinations following wisdom tooth extraction.
The research, funded by an $11 million NIH grant, analyzed outcomes from over 1,800 patients and represents one of the most comprehensive comparisons of opioid versus non-opioid pain management strategies in dental surgery. Findings challenge longstanding prescription practices and support non-opioid alternatives as first-line treatment for acute dental pain.
Study Design and Methodology
The multicenter trial employed rigorous methodology across five university dental programs:
Intervention comparison: 400mg ibuprofen + 500mg acetaminophen versus 5mg hydrocodone + acetaminophen
Gender-balanced recruitment: Intentional enrollment of equal male/female participants enabling robust subgroup analysis
Comprehensive tracking: Electronic diaries documenting pain levels, sleep quality, activity interference, and satisfaction over nine days
Standardized procedure: Focus on impacted wisdom tooth extraction—the FDA’s standard model for testing analgesics due to reliably producing 48 hours of moderate-severe pain
Key Findings and Gender-Specific Results
The analysis revealed consistent advantages for non-opioid treatment:
Superior pain control: Ibuprofen-acetaminophen combination provided better pain relief during critical first 48 hours post-surgery
Enhanced recovery: Non-opioid users reported significantly better sleep quality and less activity interference
Reduced rescue medication: Opioid recipients were twice as likely to request additional pain medication
Gender consistency: Results held equally for both male and female patients despite women typically reporting higher postoperative pain levels
Public Health Implications and Opioid Crisis Context
“These findings are particularly significant given dentistry’s role in the opioid epidemic,” noted senior author Dr. Cecil Feldman, Dean of Rutgers School of Dental Medicine. With dentists writing over 8.9 million opioid prescriptions annually—making them among the top prescribers nationally—the study provides evidence-based guidance for reducing unnecessary opioid exposure. Research shows young adults exposed to opioids through dental procedures face increased risk of future opioid misuse and addiction, contributing to over 80,000 annual overdose deaths in the United States.
Clinical Recommendations and Practice Change
The research strongly supports American Dental Association guidelines recommending non-opioids as first-line pain management. “We can state with high confidence that opioids should not be routinely prescribed for dental procedures,” Dr. Feldman emphasized.
“Our non-opioid combination should become the standard analgesic choice.” While results specifically address wisdom tooth extraction, researchers suggest similar benefits may extend to other dental surgeries, though caution against extrapolating to non-dental procedures without further study.
Future Research and Implementation Challenges
Despite compelling evidence, many dentists continue prescribing “just-in-case” opioid prescriptions. Next-phase research will investigate barriers to practice change and develop implementation strategies. “How do we now, with the evidence and knowledge we have, stop these prescriptions from being written?” questioned co-investigator Dr. Fredericks Young, highlighting the need to translate research into clinical practice.
Related topics:
